Sharps Compliance (NASDAQ:SMED) Stock Rating Lowered by TheStreet

Sharps Compliance (NASDAQ:SMED) was downgraded by equities research analysts at TheStreet from a “b-” rating to a “c+” rating in a research note issued on Tuesday, TheStreetRatingsTable reports.

A number of other research firms have also commented on SMED. Zacks Investment Research lowered Sharps Compliance from a “hold” rating to a “strong sell” rating in a research note on Wednesday. Stifel Nicolaus decreased their price objective on Sharps Compliance from $11.50 to $11.00 and set a “buy” rating on the stock in a research note on Wednesday. Barrington Research reaffirmed a “buy” rating and set a $9.00 price objective on shares of Sharps Compliance in a research note on Friday, August 21st. Finally, Lake Street Capital started coverage on Sharps Compliance in a research note on Wednesday, July 15th. They set a “buy” rating and a $10.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $9.31.

SMED stock opened at $6.10 on Tuesday. The company has a current ratio of 1.83, a quick ratio of 1.41 and a debt-to-equity ratio of 0.12. Sharps Compliance has a 12-month low of $3.74 and a 12-month high of $8.99. The company has a market cap of $100.17 million, a price-to-earnings ratio of 46.93, a PEG ratio of 2.53 and a beta of -0.45. The firm has a 50 day moving average of $6.70 and a 200-day moving average of $7.04.

Sharps Compliance (NASDAQ:SMED) last announced its earnings results on Tuesday, October 27th. The industrial products company reported ($0.02) EPS for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.06). Sharps Compliance had a net margin of 4.43% and a return on equity of 8.11%. During the same period last year, the firm posted $0.04 EPS. Sell-side analysts forecast that Sharps Compliance will post 0.11 earnings per share for the current fiscal year.

In related news, CFO Diana P. Diaz sold 9,400 shares of the stock in a transaction dated Tuesday, September 15th. The stock was sold at an average price of $7.61, for a total transaction of $71,534.00. Following the transaction, the chief financial officer now directly owns 17,975 shares in the company, valued at $136,789.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO David P. Tusa sold 28,228 shares of the stock in a transaction dated Wednesday, August 26th. The stock was sold at an average price of $7.82, for a total value of $220,742.96. Following the transaction, the chief executive officer now owns 95,559 shares in the company, valued at $747,271.38. The disclosure for this sale can be found here. Insiders have sold 122,699 shares of company stock worth $928,960 over the last quarter. 15.10% of the stock is currently owned by company insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SMED. NEXT Financial Group Inc purchased a new position in Sharps Compliance during the third quarter worth about $36,000. American International Group Inc. purchased a new position in shares of Sharps Compliance in the 2nd quarter worth about $61,000. New York State Common Retirement Fund purchased a new position in shares of Sharps Compliance in the 2nd quarter worth about $94,000. Bank of America Corp DE purchased a new position in shares of Sharps Compliance in the 2nd quarter worth about $105,000. Finally, Hancock Whitney Corp purchased a new position in shares of Sharps Compliance in the 2nd quarter worth about $121,000. Hedge funds and other institutional investors own 43.59% of the company’s stock.

About Sharps Compliance

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste generated outside the hospital and health care facility settings; TakeAway Recovery System to treat used needles, syringes, and other used healthcare products; Route-Based Pickup Service, a medical and hazardous waste pick-up services; and MedSafe, a solution for the safe collection, transportation, and disposal of unwanted and expired ultimate-user medications.

Featured Article: Can systematic risk be avoided?

Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.